Haemodynamic effects of high or low doses of furosemide in acute myocardial infarction
- PMID: 3280315
- DOI: 10.1093/oxfordjournals.eurheartj.a062465
Haemodynamic effects of high or low doses of furosemide in acute myocardial infarction
Abstract
The haemodynamic effects of high or low doses of furosemide used to prevent overt left heart failure (LHF) in acute myocardial infarction (AMI) were studied. Fifteen consecutive AMI patients without overt LHF and with a cardiac index (CI) of 2.6 +/- 0.5 l min-1 m-2, a right atrial mean pressure (RAMP) of 7 +/- 3 mmHg and a pulmonary arterial diastolic pressure (PADP) of 14 +/- 4 mmHg were investigated during 24 h. A high dose group (HDG) received 40 mg furosemide t.i.d. and a low dose group (LDG) 20 mg once daily. Following the first 40 mg of furosemide (HDG), the stroke volume index (SVI), CI, RAMP and PADP decreased. The heart rate and systemic vascular resistance index (SVRI) increased. Following the first 20 mg of furosemide (LDG), the only significant change was a decrease in PADP. After 24 h, the heart rate in the HDG was further increased; the SVI, RAMP and PADP were further reduced, whereas CI was similar to that before. In the LDG, the heart rate, SVI and CI remained unchanged. All pressures tended to decline and the SVRI was lower than in the HDG. Thus, repeated injections of 40 mg of furosemide induced a sustained preload reduction in AMI patients without overt LHF, but this was associated with potentially disadvantageous haemodynamic findings.
Similar articles
-
Hemodynamic comparison of primary venous or arteriolar dilatation and the subsequent effect of furosemide in left ventricular failure after acute myocardial infarction.Am J Cardiol. 1983 Nov 1;52(8):1036-40. doi: 10.1016/0002-9149(83)90527-1. Am J Cardiol. 1983. PMID: 6637819 Clinical Trial.
-
Renal and extrarenal hemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction.N Engl J Med. 1973 May 24;288(21):1087-90. doi: 10.1056/NEJM197305242882102. N Engl J Med. 1973. PMID: 4697939 No abstract available.
-
Haemodynamic effects of intravenous frusemide in patients with myocardial infarction and left ventricular failure.Clin Sci Mol Med. 1974 Feb;46(2):253-64. doi: 10.1042/cs0460253. Clin Sci Mol Med. 1974. PMID: 4817276 No abstract available.
-
Acute heart failure with dyspnoea: initial treatment. Furosemide and trinitrine, despite the lack of a proven survival benefit.Prescrire Int. 2011 Jun;20(117):156-60. Prescrire Int. 2011. PMID: 21678708 Review.
-
The effects of frusemide and angiotensin-converting enzyme inhibitors and their combination on cardiac and renal haemodynamics in heart failure.Eur Heart J. 1988 Feb;9(2):132-41. doi: 10.1093/oxfordjournals.eurheartj.a062466. Eur Heart J. 1988. PMID: 2832173 Review.
Cited by
-
Haemodynamic effects of diuretics in heart failure.Br Heart J. 1994 Aug;72(2 Suppl):S44-7. doi: 10.1136/hrt.72.2_suppl.s44. Br Heart J. 1994. PMID: 7946758 Free PMC article. Review. No abstract available.
-
Postinfarct heart failure: role of diuretic therapy.Cardiovasc Drugs Ther. 1993 Dec;7(6):863-7. doi: 10.1007/BF00877716. Cardiovasc Drugs Ther. 1993. PMID: 8011560 Review.
-
Diuretic therapy in elderly heart failure patients with and without left ventricular systolic dysfunction.Drugs Aging. 2000 Apr;16(4):289-300. doi: 10.2165/00002512-200016040-00005. Drugs Aging. 2000. PMID: 10874524 Review.
-
Results of clinical trials with diuretics in heart failure.Br Heart J. 1994 Aug;72(2 Suppl):S68-72. doi: 10.1136/hrt.72.2_suppl.s68. Br Heart J. 1994. PMID: 7946764 Free PMC article. Review. No abstract available.
-
Causes and treatment of oedema in patients with heart failure.Nat Rev Cardiol. 2013 Mar;10(3):156-70. doi: 10.1038/nrcardio.2012.191. Epub 2013 Jan 15. Nat Rev Cardiol. 2013. PMID: 23319101 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous